Home results
 

Keywords :   


Tag: results

Axalta Releases Third Quarter 2015 Results

2015-10-28 06:00:00| Coatings World Breaking News

Tags: results releases quarter quarter releases

 

Amkor Technology's (AMKR) CEO Steve Kelley on Q3 2015 Results - Earnings Call Transcript

2015-10-27 19:19:54| Semiconductors - Topix.net

Good day, ladies and gentlemen and welcome to the Amkor Technology Third Quarter 2015 Earnings Conference Call. My name is Latif and I will be your conference facilitator today.

Tags: results call steve ceo

 
 

Ford 3Q earnings more than double on North America results

2015-10-27 18:03:36| Automakers - Topix.net

In this June 5, 2014 file photo, the Lincoln and Ford signs mark the dealerships in Wexford, Pa. Ford Motor Co.

Tags: results north america double

 

Webinar: Time Domain Responses From Frequency Domain Results

2015-10-27 16:15:57| rfglobalnet Downloads

Time domain responses can be obtained by transforming the available frequency domain results. This webinar, presented by Altair, will discuss the signal setup in POSTFEKO and how it relates to the frequency domain specification in CADFEKO. Other topics of discussion include the benefits of transforming frequency domain results as a post-processing step, and examples of EMP pulse propagation on an overhead transmission line and time domain reflectometry.

Tags: time results domain frequency

 

Merck Announces Third-Quarter 2015 Financial Results

2015-10-27 11:45:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. Increased Non-GAAP EPS by 7 Percent to $0.96; GAAP EPS of $0.64 Raised 2015 Full-Year Non-GAAP EPS Target to a Range of $3.55 $3.60 and GAAP EPS Target to a Range of $1.64 $1.74 Worldwide Sales Were $10.1 Billion, a Decrease of 5 Percent; Excluding the Impact of Foreign Exchange, Acquisitions and Divestitures, Worldwide Sales Grew 4 Percent Advanced KEYTRUDA Program FDA Approved sBLA for the Treatment of Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1 In KEYNOTE-010 Study KEYTRUDA Showed Superior Overall Survival Compared to Chemotherapy in Patients with Previously Treated Advanced NSCLC Whose Tumors Express PD-L1 Third-Quarter Sales Were Approximately $160 million KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2015. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036Steven Cragle, 908-740-1801orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1789 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: results financial announces merck

 

Sites : [429] [430] [431] [432] [433] [434] [435] [436] [437] [438] [439] [440] [441] [442] [443] [444] [445] [446] [447] [448] next »